Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for Alzheimer's disease brain atrophy reduction
ISRCTN93682878Phase 2Completed
- Sponsor
- North Bristol NHS Trust
- Start
- Oct 2013
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Placebo with Losartan (2 arms). Primary endpoint: Change in whole brain volume. Started Oct 2013; status: completed.
02
Drugs
losartan
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on ISRCTN93682878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN93682878.